Vivos Therapeutics, Inc. financial data

Symbol
VVOS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
7921 Southpark Plaza,, Suite 210, Littleton, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Vivos BioTechnologies, Inc. (to 9/29/2017)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 78.6 % +11.3%
Debt-to-equity 258 % -12.1%
Return On Equity -335 % +24.2%
Return On Assets -93.6 % +16.7%
Operating Margin -85.7 % +35.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.84M shares +304%
Common Stock, Shares, Outstanding 4.77M shares +298%
Entity Public Float 15.3M USD -34.1%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 6.62M shares +453%
Weighted Average Number of Shares Outstanding, Diluted 6.62M shares +453%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.6M USD +0.54%
Research and Development Expense 100K USD -50%
Selling and Marketing Expense 1.93M USD -47.1%
General and Administrative Expense 19M USD -19%
Operating Income (Loss) -12.5M USD +34.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.6M USD +18.5%
Net Income (Loss) Attributable to Parent -12.6M USD +18.5%
Earnings Per Share, Basic -5.68 USD/shares +79%
Earnings Per Share, Diluted -5.68 USD/shares +79%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.31M USD +539%
Accounts Receivable, after Allowance for Credit Loss, Current 454K USD +99.1%
Assets, Current 7.4M USD +273%
Property, Plant and Equipment, Net 3.32M USD +1.04%
Operating Lease, Right-of-Use Asset 1.13M USD -23%
Intangible Assets, Net (Excluding Goodwill) 383K USD -11.5%
Goodwill 2.84M USD 0%
Assets 15.3M USD +48.8%
Accounts Payable, Current 1.08M USD -29.6%
Accrued Liabilities, Current 2.05M USD +6.87%
Contract with Customer, Liability, Current 1.31M USD -44.7%
Liabilities, Current 5.13M USD -28.5%
Long-term Debt and Lease Obligation 1.2M USD 0%
Contract with Customer, Liability, Noncurrent 178K USD -25.8%
Operating Lease, Liability, Noncurrent 1.16M USD -29.6%
Liabilities 7.68M USD -25.2%
Retained Earnings (Accumulated Deficit) -101M USD -14.2%
Stockholders' Equity Attributable to Parent 7.67M USD +16563%
Liabilities and Equity 15.3M USD +48.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.52M USD +28.9%
Net Cash Provided by (Used in) Financing Activities 3.64M USD -50.6%
Net Cash Provided by (Used in) Investing Activities -151K USD +47.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 4.77M shares +298%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 968K USD -72.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -60%
Deferred Tax Assets, Valuation Allowance 19.3M USD +23.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19.7M USD +22.7%
Operating Lease, Liability 1.76M USD -20.2%
Depreciation 600K USD +50%
Payments to Acquire Property, Plant, and Equipment 151K USD -36.8%
Lessee, Operating Lease, Liability, to be Paid 2.05M USD -23.1%
Property, Plant and Equipment, Gross 6.04M USD +10.4%
Operating Lease, Liability, Current 485K USD +5.44%
Lessee, Operating Lease, Liability, to be Paid, Year Two 507K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 594K USD -4.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 282K USD -37.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD -2.76%
Deferred Tax Assets, Operating Loss Carryforwards 17.4M USD +25.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -73%
Operating Lease, Payments 153K USD
Additional Paid in Capital 109M USD +22.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Depreciation, Depletion and Amortization 146K USD -16.6%
Deferred Tax Assets, Net of Valuation Allowance 340K USD -13.7%
Share-based Payment Arrangement, Expense 100K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%